3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Leukemia, Biphenotypic, Acute
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Ganglioneuroblastoma
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Recurrence
1
Neuroblastoma
1
Medulloblastoma
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Mast-Cell
1
Leukemia, Large Granular Lymphocytic
1
Leukemia
1
Graft vs Host Disease
1
GATA2 Deficiency
1
Burkitt Lymphoma
1
Blast Crisis
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Nivolumab
22
Specimen Handling
17
pembrolizumab
13
cabozantinib
13
Magnetic Resonance Spectroscopy
13
belzutifan
12
Ipilimumab
12
lenvatinib
7
Axitinib
7
CTLA-4 Antigen
6
Biopsy
6
atezolizumab
4
Sunitinib
4
tivozanib
3
Surveys and Questionnaires
3
Immunoglobulin G
3
Everolimus
3
Disulfides
3
relatlimab
2
pazopanib
2
palbociclib
2
aldesleukin
2
Watchful Waiting
2
Standard of Care
2
Radiosurgery
2
Practice Guidelines as Topic
2
Nephrectomy
2
Bevacizumab
2
zimberelimab
1
ulixertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Thiotepa
×
30 days
×
Clear all
No trials found.